- Home
- NPCE vs FRA Comparison
NPCE vs FRA Comparison
Compare NPCE & FRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NPCE | FRA |
|---|---|---|
| Founded | 1997 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 485.6M | 415.1M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | NPCE | FRA |
|---|---|---|
| Price | $13.36 | $10.59 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $18.33 | N/A |
| AVG Volume (30 Days) | ★ 232.0K | 180.8K |
| Earning Date | 03-03-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.06% |
| EPS Growth | ★ 29.03 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $99,986,000.00 | N/A |
| Revenue This Year | $0.90 | N/A |
| Revenue Next Year | $24.46 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.13 | N/A |
| 52 Week Low | $7.56 | $10.50 |
| 52 Week High | $18.97 | $13.41 |
Technical Indicators
Market Signals| Indicator | NPCE | FRA |
|---|---|---|
| Relative Strength Index (RSI) | 40.71 | 25.77 |
| Support Level | $12.54 | N/A |
| Resistance Level | $13.81 | $13.05 |
| Average True Range (ATR) | 0.58 | 0.15 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 33.82 | 7.69 |
Price Performance
Historical ComparisonAbout NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.
About FRA Blackrock Floating Rate Income Strategies Fund Inc
Blackrock Floating Rate Inc Stra Fd Inc is a United States-based diversified closed-ended management investment company. The Fund's investment objective is to provide shareholders with high current income and preservation of capital with investment in a diversified, leveraged portfolio consisting of floating-rate debt securities and instruments.